BionTech Covid-19 Vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা
The Business Standard
SATURDAY, FEBRUARY 27, 2021
SATURDAY, FEBRUARY 27, 2021
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা

BionTech Covid-19 Vaccine

Coronavirus chronicle

Unilever gets vaccine partnership offers as it plots worker safety strategy

Costing as much as $19.50 per dose, 200,000 doses of the vaccine made by Pfizer and BioNTech could cost nearly $4 million

Coronavirus chronicle

BioNTech aims for 2 billion Covid-19 vaccine doses in 2021

Coronavirus chronicle

BioNTech founders warn of vaccine supply gaps

Coronavirus chronicle

China's Fosun plans plant to make BioNTech's Covid-19 vaccine -Caixin

Coronavirus chronicle

EU starts mass vaccination in 'touching moment of unity'

World

Mutated Covid-19 variant could make herd immunity more difficult: BioNTech boss

Coronavirus chronicle

UK approves Pfizer-BioNTech vaccine for use

Coronavirus chronicle

Covid-19 vaccine: The next steps

Coronavirus chronicle

Sanofi says its vaccine won’t need supercooling

Coronavirus chronicle

Vaccine scientist hopes for return to ‘normal’ by next winter

Coronavirus chronicle

Covid-19: BioNTech CEO says normal life by next winter

Global Economy

Vaccine is inexact bonus for freight and freezers

Coronavirus chronicle

China approves Shanghai Fosun's unit to run human testing for BioNTech's Covid-19 vaccine

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]

Copyright © 2021 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab